Please use this identifier to cite or link to this item:
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12136]
Metadata
Show full item record
PFKELCH13 PLASMODIUM FALCIPARUM MUTATIONS IN HUAMBO, ANGOLA
Author
Affilliation
Abstract
Artemisinin (ART) is recommended as the first-line drug for P. falciparum infections combined
with a long-acting partner drug. The emergence of P. falciparum resistance to ART (ARTR) is a
concern for malaria. The most feared threat remains the spread of ARTR from Southeast Asia to Africa
or the independent emergence of ARTR in Africa, where malaria accounts for 93% of all malaria
cases and 94% of deaths. To avoid this worst-case scenario, surveillance of Pfkelch13 mutations is
essential. We investigated mutations of Pfkelch13 in 78 P. falciparum samples from Huambo, Angola.
Most of the parasites had a wild-type Pfkelch13 allele. We identified one synonymous mutation
(R471R) in 10 isolates and one non-synonymous mutation (A578S) in two samples. No Pfkelch13
validated or candidate ARTR mutants were identified. The finding suggests that there is little polymorphism
in Pfkelch13 in Huambo. Since cases of late response to ART in Africa and the emergence
of ARTR mutations in Rwanda and Uganda have been reported, efforts should be made toward
continuous molecular surveillance of ARTR. Our study has some limitations. Since we analyzed
P. falciparum parasites from a single health facility, the study may not be representative of all Angolan
endemic areas.
Share